Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Carpenter AAM"'
Autor:
Albert Koulman, Wilczynska A, Elena Loche, Antonia S. Hufnagel, Isabella Inzani, Susan E. Ozanne, Samuel Furse, Lucas Carminatti Pantaleão, Martin Bushell, Benjamin Jenkins, Carpenter Aam, Thomas J. Ashmore, Denise S. Fernandez-Twinn, Heather L. Blackmore
Maternal obesity during pregnancy has immediate and long-term detrimental effects on the offspring heart. In this study, we characterized the cardiac and circulatory lipid profiles in fetuses of diet-induced obese pregnant mice and established the ch
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2e8d1ea97a93cb305f13d72cdcba9d62
https://doi.org/10.1101/2021.04.12.439435
https://doi.org/10.1101/2021.04.12.439435
Previous studies have shown that maternal diet-induced obesity leads to increased risk of type 2 diabetes in offspring. The current study investigated if weaning onto an obesogenic diet exaggerated the detrimental effects of maternal diet-induced obe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::98c998608cf782d11a52c1d529bd39db
Autor:
Mennitti LV; Department of Bioscience, Laboratory of Nutrition and Endocrine Physiology, Federal University of São Paulo, Santos, 11015-020, Brazil.; Metabolic Research Laboratories and MRC Metabolic Diseases Unit, University of Cambridge, Cambridge, CB2 OQQ, United Kingdom., Carpenter AAM; Metabolic Research Laboratories and MRC Metabolic Diseases Unit, University of Cambridge, Cambridge, CB2 OQQ, United Kingdom., Loche E; Metabolic Research Laboratories and MRC Metabolic Diseases Unit, University of Cambridge, Cambridge, CB2 OQQ, United Kingdom., Pantaleão LC; Metabolic Research Laboratories and MRC Metabolic Diseases Unit, University of Cambridge, Cambridge, CB2 OQQ, United Kingdom., Fernandez-Twinn DS; Metabolic Research Laboratories and MRC Metabolic Diseases Unit, University of Cambridge, Cambridge, CB2 OQQ, United Kingdom., Schoonejans JM; Metabolic Research Laboratories and MRC Metabolic Diseases Unit, University of Cambridge, Cambridge, CB2 OQQ, United Kingdom., Blackmore HL; Metabolic Research Laboratories and MRC Metabolic Diseases Unit, University of Cambridge, Cambridge, CB2 OQQ, United Kingdom., Ashmore TJ; Metabolic Research Laboratories and MRC Metabolic Diseases Unit, University of Cambridge, Cambridge, CB2 OQQ, United Kingdom., Pisani LP; Department of Bioscience, Laboratory of Nutrition and Endocrine Physiology, Federal University of São Paulo, Santos, 11015-020, Brazil.; Metabolic Research Laboratories and MRC Metabolic Diseases Unit, University of Cambridge, Cambridge, CB2 OQQ, United Kingdom., Tadross JA; Metabolic Research Laboratories and MRC Metabolic Diseases Unit, University of Cambridge, Cambridge, CB2 OQQ, United Kingdom.; Department of Pathology, University of Cambridge, Cambridge, CB2 1QP, United Kingdom., Hargreaves I; Department of Pharmacy and Biomolecular Science, Liverpool John Moores University, Byrom Street, Liverpool, L3 5UA, United Kingdom., Ozanne SE; Metabolic Research Laboratories and MRC Metabolic Diseases Unit, University of Cambridge, Cambridge, CB2 OQQ, United Kingdom. seo10@cam.ac.uk.
Publikováno v:
International journal of obesity (2005) [Int J Obes (Lond)] 2022 Feb; Vol. 46 (2), pp. 269-278. Date of Electronic Publication: 2021 Oct 18.
Autor:
Pantaleão LC; Wellcome-MRC Institute of Metabolic Science and Medical Research Council Metabolic Diseases Unit, University of Cambridge, Addenbrooke's Hospital, Cambridge, United Kingdom., Inzani I; Wellcome-MRC Institute of Metabolic Science and Medical Research Council Metabolic Diseases Unit, University of Cambridge, Addenbrooke's Hospital, Cambridge, United Kingdom., Furse S; Wellcome-MRC Institute of Metabolic Science and Medical Research Council Metabolic Diseases Unit, University of Cambridge, Addenbrooke's Hospital, Cambridge, United Kingdom.; Core Metabolomics and Lipidomics Laboratory, Wellcome-MRC Institute of Metabolic Science, University of Cambridge, Addenbrooke's Treatment Centre, Cambridge, United Kingdom., Loche E; Wellcome-MRC Institute of Metabolic Science and Medical Research Council Metabolic Diseases Unit, University of Cambridge, Addenbrooke's Hospital, Cambridge, United Kingdom., Hufnagel A; Wellcome-MRC Institute of Metabolic Science and Medical Research Council Metabolic Diseases Unit, University of Cambridge, Addenbrooke's Hospital, Cambridge, United Kingdom., Ashmore T; Wellcome-MRC Institute of Metabolic Science and Medical Research Council Metabolic Diseases Unit, University of Cambridge, Addenbrooke's Hospital, Cambridge, United Kingdom., Blackmore HL; Wellcome-MRC Institute of Metabolic Science and Medical Research Council Metabolic Diseases Unit, University of Cambridge, Addenbrooke's Hospital, Cambridge, United Kingdom., Jenkins B; Wellcome-MRC Institute of Metabolic Science and Medical Research Council Metabolic Diseases Unit, University of Cambridge, Addenbrooke's Hospital, Cambridge, United Kingdom.; Core Metabolomics and Lipidomics Laboratory, Wellcome-MRC Institute of Metabolic Science, University of Cambridge, Addenbrooke's Treatment Centre, Cambridge, United Kingdom., Carpenter AAM; Wellcome-MRC Institute of Metabolic Science and Medical Research Council Metabolic Diseases Unit, University of Cambridge, Addenbrooke's Hospital, Cambridge, United Kingdom., Wilczynska A; Cancer Research UK Beatson Institute, Glasgow, United Kingdom.; Institute of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom., Bushell M; Cancer Research UK Beatson Institute, Glasgow, United Kingdom.; Institute of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom., Koulman A; Wellcome-MRC Institute of Metabolic Science and Medical Research Council Metabolic Diseases Unit, University of Cambridge, Addenbrooke's Hospital, Cambridge, United Kingdom.; Core Metabolomics and Lipidomics Laboratory, Wellcome-MRC Institute of Metabolic Science, University of Cambridge, Addenbrooke's Treatment Centre, Cambridge, United Kingdom., Fernandez-Twinn DS; Wellcome-MRC Institute of Metabolic Science and Medical Research Council Metabolic Diseases Unit, University of Cambridge, Addenbrooke's Hospital, Cambridge, United Kingdom., Ozanne SE; Wellcome-MRC Institute of Metabolic Science and Medical Research Council Metabolic Diseases Unit, University of Cambridge, Addenbrooke's Hospital, Cambridge, United Kingdom.
Publikováno v:
ELife [Elife] 2022 Jan 13; Vol. 11. Date of Electronic Publication: 2022 Jan 13.